COVID-19 相关肝损伤：病理发现。
Liver injury in COVID-19: pathological findings.
机构信息
Department of Pathology, Habib Bourguiba University Hospital, El Ain, Sfax, Tunisia.
出版信息
Pan Afr Med J. 2022 Jan 20;41:56. doi: 10.11604/pamj.2022.41.56.31114. eCollection 2022.
Abstract
Hepatic injuries have been reported in patients with Coronavirus disease 2019 infection, particularly in those with moderate to severe illness. To date, pathological changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liver tissue are unclear. Moreover, the mechanisms involved in liver injury in Coronavirus disease 2019 infection are not yet established. In this paper, we summarize the spectrum of pathologic findings of liver injury in patients infected by SARS-CoV-2 and we discuss the clinicopathological correlation and the mechanisms of liver damage in Coronavirus disease 2019 infection.
摘要
据报道，2019 年冠状病毒病（COVID-19）感染患者存在肝损伤，特别是在中度至重度疾病患者中。迄今为止，严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）引起的肝组织病理变化尚不清楚。此外，COVID-19 感染导致肝损伤的机制尚不清楚。在本文中，我们总结了感染 SARS-CoV-2 的患者的肝损伤病理发现谱，并讨论了 COVID-19 感染中肝损伤的临床病理相关性和机制。
相似文献
1
Liver injury in COVID-19: pathological findings.COVID-19 相关肝损伤：病理发现。
Pan Afr Med J. 2022 Jan 20;41:56. doi: 10.11604/pamj.2022.41.56.31114. eCollection 2022.
2
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
3
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
4
COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells.COVID-19 与肝损伤：不同肝脏细胞中的细胞和分子机制。
World J Gastroenterol. 2023 Jan 21;29(3):425-449. doi: 10.3748/wjg.v29.i3.425.
5
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
6
Liver infection and COVID-19: the electron microscopy proof and revision of the literature.肝脏感染与 COVID-19：电子显微镜证据与文献回顾。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):2146-2151. doi: 10.26355/eurrev_202102_25120.
7
SARS-CoV-2-induced liver injury: A review article on the high-risk populations, manifestations, mechanisms, pathological changes, management, and outcomes.SARS-CoV-2 诱导的肝损伤：一篇综述文章，讨论了高危人群、临床表现、发病机制、病理变化、治疗方法和预后。
World J Gastroenterol. 2022 Oct 21;28(39):5723-5730. doi: 10.3748/wjg.v28.i39.5723.
8
Pathogenesis of coronavirus disease 2019-associated kidney injury.2019冠状病毒病相关肾损伤的发病机制。
Curr Opin Nephrol Hypertens. 2021 May 1;30(3):324-331. doi: 10.1097/MNH.0000000000000708.
9
Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target.新冠病毒相关肝损伤中的铁死亡：一种潜在的机制和治疗靶点。
Front Cell Infect Microbiol. 2022 Jul 27;12:922511. doi: 10.3389/fcimb.2022.922511. eCollection 2022.
10
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.冠状病毒相关性肾病的病理诊断：来自尸检研究的见解。
Crit Rev Clin Lab Sci. 2021 Dec;58(8):563-575. doi: 10.1080/10408363.2021.1944047. Epub 2021 Jul 8.
引用本文的文献
1
Effects of COVID-19 on the Liver and Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta and Non-Delta Variants: An Analysis in a Single Centre.新型冠状病毒肺炎（COVID-19）对由德尔塔和非德尔塔变异株引起的新型冠状病毒肺炎患者肝脏及死亡率的影响：单中心分析
Pharmaceuticals (Basel). 2023 Dec 19;17(1):3. doi: 10.3390/ph17010003.
2
Effect of SARS-CoV-2 infection on the liver.新型冠状病毒2019感染对肝脏的影响。
World J Virol. 2023 Mar 25;12(2):109-121. doi: 10.5501/wjv.v12.i2.109.
3
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment.与新冠病毒感染相关的肝损伤：发病机制、组织病理学、预后及治疗
J Clin Med. 2023 Mar 6;12(5):2067. doi: 10.3390/jcm12052067.
4
Pathologic Characteristics of Digestive Tract and Liver in Patients with Coronavirus Disease 2019.2019冠状病毒病患者消化道和肝脏的病理特征
Gastroenterol Clin North Am. 2023 Mar;52(1):201-214. doi: 10.1016/j.gtc.2022.09.003. Epub 2022 Oct 4.
5
Potential risk of liver injury in epileptic patients during COVID-19 pandemic.新冠疫情期间癫痫患者发生肝损伤的潜在风险。
World J Virol. 2022 Nov 25;11(6):467-476. doi: 10.5501/wjv.v11.i6.467.
6
COVID-19 and hepatorenal syndrome.COVID-19 与肝肾综合征。
World J Gastroenterol. 2022 Oct 21;28(39):5666-5678. doi: 10.3748/wjg.v28.i39.5666.
7
Evaluation of Drug-Induced Liver Injury in Hospitalized Patients with SARS-CoV-2 Infection.新型冠状病毒肺炎住院患者药物性肝损伤的评估
Microorganisms. 2022 Oct 17;10(10):2045. doi: 10.3390/microorganisms10102045.
8
Evaluation of FIB-4, NFS, APRI and Liver Function Tests as Predictors for SARS-CoV-2 Infection in the Elderly Population: A Matched Case-Control Analysis.FIB-4、NFS、APRI及肝功能检查作为老年人群中新型冠状病毒感染预测指标的评估：一项配对病例对照分析
J Clin Med. 2022 Aug 31;11(17):5149. doi: 10.3390/jcm11175149.
本文引用的文献
1
Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.肝组织中严重急性呼吸综合征冠状病毒 2 感染的研究结果。
Cell Mol Gastroenterol Hepatol. 2021;11(3):763-770. doi: 10.1016/j.jcmgh.2020.09.015. Epub 2020 Sep 28.
2
Histopathological features of multiorgan percutaneous tissue core biopsy in patients with COVID-19.新型冠状病毒肺炎患者多器官经皮组织芯活检的组织病理学特征
J Clin Pathol. 2021 Aug;74(8):522-527. doi: 10.1136/jclinpath-2020-206623. Epub 2020 Aug 26.
3
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.巨核细胞和血小板-纤维蛋白血栓是新冠病毒病尸检时多器官血栓形成的特征：病例系列
EClinicalMedicine. 2020 Jun 25;24:100434. doi: 10.1016/j.eclinm.2020.100434. eCollection 2020 Jul.
4
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
5
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
6
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.通过尸体核心活检对 2019 年新型冠状病毒病（COVID-19）的病理学研究。
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
7
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.新型冠状病毒肺炎患者的非酒精性脂肪性肝病：一项回顾性研究。
J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
8
Gross examination report of a COVID-19 death autopsy.一份新冠死亡病例尸检大体检查报告。
Fa Yi Xue Za Zhi. 2020 Feb;36(1):21-23. doi: 10.12116/j.issn.1004-5619.2020.01.005. Epub 2020 Feb 25.
9
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
Zotero 插件